Differential effects of tyrosine kinase inhibitors and an inhibitor of the mitogen-activated protein kinase cascade on degranulation and superoxide production of human neutrophil granulocytes

被引:43
作者
Mocsai, A
Banfi, B
Kapus, A
Farkas, G
Geiszt, M
Buday, L
Farago, A
Ligeti, E
机构
[1] SEMMELWEIS UNIV MED, DEPT PHYSIOL, H-1444 BUDAPEST, HUNGARY
[2] SEMMELWEIS UNIV MED, LAB MOL & CELLULAR PHYSIOL, H-1444 BUDAPEST, HUNGARY
[3] SEMMELWEIS UNIV MED, DEPT MED CHEM MOL BIOL & PATHOBIOCHEM, H-1444 BUDAPEST, HUNGARY
关键词
neutrophil granulocytes; superoxide production; exocytosis; tyrosine kinases; MAP kinase; signal transduction;
D O I
10.1016/S0006-2952(97)00245-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of two different tyrosine kinase inhibitors (genistein and erbstatin analog) and an inhibitor (2'-amino-3'-methoxyflavone; PD98059) of the mitogen-activated protein (MAP) kinase kinase on the primary granule exocytosis and superoxide O-2(radical anion) production of human neutrophil granulocytes were compared. The effector responses induced by stimulation of the chemotactic receptors by formyl-methionyl-leucyl-phenylalanine and platelet-activating factor were blocked both by genistein and erbstatin analog. In contrast, degranulation and O-2(radical anion) production triggered by the activation of protein kinase C with phorbol-12-myristate-13-acetate were reduced by erbstatin analog but not by genistein. This inhibitory pattern was observed in both effector responses, but the sensitivity of O-2(radical anion) production toward tyrosine kinase inhibition was markedly higher than that of degranulation. PD98059 caused no considerable effect on any of the above responses. The data presented indicate that tyrosine kinases are involved not only in the respiratory burst but also in the organization of the degranulation response of neutrophil granulocytes. It is suggested that several tyrosine kinases of different inhibitor sensitivity may particulate in the transduction of extracellular signals. However, activation of the MAP kinase cascade does not appear to be involved in either of the investigated biological responses of the neutrophils. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:781 / 789
页数:9
相关论文
共 36 条
  • [1] PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO
    ALESSI, DR
    CUENDA, A
    COHEN, P
    DUDLEY, DT
    SALTIEL, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) : 27489 - 27494
  • [2] ACTIVATION OF THE RESPIRATORY BURST AND TYROSINE PHOSPHORYLATION OF PROTEINS IN HUMAN NEUTROPHILS - NO DIRECT RELATIONSHIP AND INVOLVEMENT OF PROTEIN-KINASE C-DEPENDENT AND C-INDEPENDENT SIGNALING PATHWAYS
    AZUMA, EK
    KITAGAWA, S
    YUO, A
    MIZOGUCHI, H
    UMEZAWA, K
    TAKAKU, F
    SAITO, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1179 (02) : 213 - 223
  • [3] BERKOW RL, 1990, BLOOD, V75, P2445
  • [4] HUMAN-NEUTROPHILS CONTAIN DISTINCT CYTOSOLIC AND PARTICULATE TYROSINE KINASE-ACTIVITIES - POSSIBLE ROLE IN NEUTROPHIL ACTIVATION
    BERKOW, RL
    DODSON, RW
    KRAFT, AS
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 997 (03) : 292 - 301
  • [5] INHIBITION OF PROTEIN-KINASE-C BY THE TYROSINE KINASE INHIBITOR ERBSTATIN
    BISHOP, WR
    PETRIN, J
    WANG, L
    RAMESH, U
    DOLL, RJ
    [J]. BIOCHEMICAL PHARMACOLOGY, 1990, 40 (09) : 2129 - 2135
  • [6] CHEMOATTRACTANT SIGNALING AND LEUKOCYTE ACTIVATION
    BOKOCH, GM
    [J]. BLOOD, 1995, 86 (05) : 1649 - 1660
  • [7] BORREGAARD N, 1993, EUR J HAEMATOL, V51, P187
  • [8] SERINE/THREONINE KINASE ACTIVATION IN HUMAN NEUTROPHILS - RELATIONSHIP TO TYROSINE PHOSPHORYLATION
    BRUMELL, JH
    GRINSTEIN, S
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1994, 267 (06): : C1574 - C1581
  • [9] PROTEOLYTIC ACTIVATION OF PROTEIN-KINASE-C IN THE EXTRACTS OF CELLS TREATED FOR A SHORT-TIME WITH PHORBOL ESTER
    BUDAY, L
    SEPRODI, J
    FARKAS, G
    MESZAROS, G
    ROMHANYI, T
    BANHEGYI, G
    MANDL, J
    ANTONI, F
    FARAGO, A
    [J]. FEBS LETTERS, 1987, 223 (01) : 15 - 19
  • [10] CUI Y, 1994, J IMMUNOL, V152, P5420